AI Is Hunting the Next Pandemic, and the Model Is the Easy Part
By M. Mahmood, Strategist & Consultant, mmmahmood.com
Summary / TL;DR
AI can now discover unknown viruses, scan outbreak signals in 65 languages, and flag spillover risk before cases climb. That progress creates a decision for every health minister, donor, and enterprise risk leader: fund AI pandemic prediction as a centerpiece technology, or fund the field reporting, laboratories, and community trust that determine whether any prediction matters. This article argues the second path wins, and the evidence supports it.
Researchers at Stanford's collaborators and the University of Sydney have built models that found more than 70,000 previously unknown RNA virus species in public data. BlueDot flagged Miami as a Zika risk before 1,471 cases were documented in Florida, and HealthMap sent the world's first COVID-19 alert in late 2019. Yet the scientists building these systems keep repeating the same warning: algorithms cannot overcome missing samples, underreported outbreaks, or governments that hide bad news. The model is advancing quickly, yet everything around the model is not.
The consensus says better models will spot the next pandemic
The prevailing view holds that AI pandemic prediction will mature into a global early warning system, where machine learning scans genomic data, news reports, and travel patterns to catch spillover before humans notice. Parts of that system already exist in research settings. The open question is whether prediction converts into prevention, and that conversion depends on institutions far more than on algorithms.
The field work sounds impressive, and it is. In Uganda, the nonprofit Conservation Through Public Health spent three years in a collaboration that ended in March 2026 collecting samples from cattle and poultry around Bwindi Impenetrable National Park, testing them for diseases such as brucellosis and Rift Valley fever, and feeding the results into predictive models designed as early warning systems for people, livestock, and gorillas, according to Nature's report on AI and zoonotic disease tracking. This is the One Health idea made real: watch animals, people, and ecosystems together, because most emerging human diseases originate in other animals.
Funding narratives have followed the technology. Climate change, deforestation, and live animal markets increase contact between species, which raises spillover frequency, so investors and governments increasingly treat outbreak AI as inevitable infrastructure. The consensus concludes that better models will close the gap. That conclusion deserves a harder look.
What the evidence says about AI pandemic prediction
The evidence shows genuine technical progress on three fronts: virus discovery, outbreak detection, and risk forecasting. Models have identified viruses never seen in nature, flagged outbreaks ahead of official announcements, and mapped future disease risk across continents. What the evidence does not yet show is a prediction pipeline that reliably triggers a funded, fast public-health response.
Start with discovery. Edward Holmes at the University of Sydney and his collaborators built LucaProt, a deep-learning system that screens protein structures from sequencing data. In 2024, they ran it across 10,487 public metatranscriptome datasets and identified 161,979 RNA virus species, of which 70,458 had never been recorded before, the largest virus discovery in a single study, as the Nature investigation documents. A University of Glasgow team published a machine-learning method in 2021 that predicts which animal viruses could cross into humans, and United States researchers described a model earlier this year that identifies likely disease hosts and recommends when field sampling would pay off.
Detection tells a similar story. BlueDot, a Toronto company serving clients such as the Gulf Center for Disease Prevention and Control and the City of Chicago, filters thousands of articles and official reports in 65 languages, then layers in air-travel data to estimate which outbreaks connect to which cities. Its researchers identified Miami as a Zika risk in 2015 by combining mosquito ecology, temperature profiles, and flight data from Brazil; Florida went on to document 1,471 cases. HealthMap, built at Boston Children's Hospital two decades ago, issued the first alert anywhere on the disease later named COVID-19 in late 2019, and its successor project BEACON has drawn more than 227,000 users across 233 countries and territories since 2025.
These are real achievements. They also share a quiet pattern: every success story involves scientists who already had data access, laboratory capacity, and institutions willing to listen. Strip away any one of those, and the model becomes a very sophisticated observer of a fire nobody fights.
Why the model is the easy part of outbreak response
AI pandemic prediction fails at the last mile, where a probability estimate must become a decision by a specific official with budget and authority. Models operate on data that humans choose to collect and share. Politics, funding cycles, stigma, and weak laboratories all shape that data long before any algorithm sees it, which makes the institutional layer the true bottleneck in outbreak prevention.
Holmes himself puts it plainly in the Nature report: "It's a politics and people problem." The economics argue for solving it. A 2022 World Bank estimate cited in the same reporting values One Health-style prevention at up to $11.5 billion per year, roughly one-third the cost of managing pandemics after they ignite. Prevention is cheaper by a factor of three, yet the money still flows toward response, because response has a visible emergency and prevention has a spreadsheet.
The scientific caution runs deeper than funding. Writing in The Lancet Infectious Diseases in January, virologists at the Pasteur Institute of Iran warned that combining AI with metagenomic sequencing cannot, by itself, resolve the fundamental uncertainties in how pathogens emerge. Community inclusion poses a second risk: epidemiologists and socio-anthropologists told Nature that models trained without local knowledge from low- and middle-income countries can bake in bias, missing exactly the signals from the places where spillover risk runs highest.
In my experience building AI programs and a $100M generative AI business inside large organizations, the model was almost never the constraint. The constraint was who reported data, who trusted the output enough to act on it, and who owned the decision when the prediction arrived at 2 a.m. on a weekend. Disease surveillance compresses all three problems into one pipeline, then adds politics. A ministry that fears trade damage from an outbreak announcement has every incentive to delay reporting, and no model architecture fixes an incentive.
The operating model that turns prediction into prevention
A working outbreak early warning system has six layers, and the model sits fourth. Field sampling, community trust, and data plumbing come first; decision rights and governance come last. Leaders who fund the layers in the wrong order end up with accurate forecasts nobody acts on, which is the most expensive way to be right.
| Layer | What leaders actually fund | Failure mode when skipped |
|---|---|---|
| Field sampling and laboratories | Trained local staff, specimen collection, sequencing capacity at spillover fault lines | The model sees nothing because nothing was measured |
| Community trust | Local partnerships, benefit sharing, transparent communication with affected communities | People hide cases, refuse testing, and the data stream silently degrades |
| Data infrastructure | Interoperable reporting across veterinary, human health, and environmental agencies | Signals arrive fragmented, late, or in formats the model cannot use |
| Model layer | Discovery tools, forecasting systems, and multilingual signal filtering | Without the first three layers, this layer produces confident noise |
| Decision layer | Pre-authorized playbooks that specify who acts at which probability threshold | Alerts circulate in email while the window for cheap intervention closes |
| Governance | Independent audit of model bias, false-alarm rates, and response speed | Alert fatigue sets in and the next real warning gets ignored |
Notice what this ordering implies for procurement. An AI vendor evaluation framework that scores only model accuracy and price will miss the layers where outbreaks are actually won. Buyers should score vendors on data integration with veterinary and environmental sources, on documented false-alarm rates, and on whether the vendor's deployment plan includes local laboratory training. The same discipline applies inside health systems adopting broader automation, as the healthcare findings in the enterprise deployment framework for physical AI make clear: regulatory validation and data readiness set the pace, not model capability.
A 90 to 180 day playbook for AI pandemic prediction
Leaders can move from slideware to an operating early warning capability in six months by assigning owners across public health, data, finance, and governance. The sequence matters: measurement and trust come before model procurement, and decision rights come before any system goes live. Each milestone below has a named owner and a concrete deliverable.
- Days 1 to 30, Director of the national public health institute: Map the spillover fault lines that matter most, such as live animal markets, poultry farms, and settlements near bat roosts, then audit which of them have any sampling coverage at all. Deliverable: a coverage map with the gaps priced.
- Days 15 to 60, Chief Data Officer: Inventory every data source across human health, veterinary, and environmental agencies, and identify which streams can legally and technically feed a shared early warning system. Deliverable: an interoperability assessment with three prioritized integrations.
- Days 30 to 90, Finance ministry or donor CFO: Rebalance the portfolio using the World Bank prevention arithmetic reported by Nature, shifting a defined share of emergency response budget into standing surveillance capacity. AI cost allocation discipline applies here directly, because surveillance that no P&L owns becomes the first cut in every budget cycle.
- Days 60 to 120, Procurement lead: Run any AI vendor through a scorecard that weights data integration, false-alarm history, and local capacity building above demonstration accuracy. Deliverable: a signed contract with decision thresholds and escalation paths written in, not appended later.
- Days 90 to 150, Community engagement lead: Establish benefit-sharing and communication protocols with the communities where sampling occurs, because predictive analytics only performs as well as its input data, and input data in the field depends on human cooperation.
- Days 120 to 180, Board or ministerial oversight committee: Adopt a governance charter covering model bias audits, alert fatigue metrics, and response-time review, modeled on board-level AI governance practice in the private sector. Deliverable: a signed charter plus the first scheduled drill.
Who loses if leaders buy the hype
Three groups lose when AI pandemic prediction gets purchased as a model instead of a system. Governments that buy dashboards without field networks lose twice: they pay for the software and still miss the outbreak. Vendors who oversell prevention claims lose credibility the first time a real event exposes the gap between the demo and the data. Donors who fund pilots with no operational handoff lose entire portfolios of good intentions.
The deepest loss lands on the communities least visible in the training data. If models learn outbreak patterns primarily from well-instrumented wealthy regions, the tools will work best exactly where they are needed least. That is a design choice dressed up as a technical outcome, and leaders can reverse it by funding sampling and trust in low- and middle-income countries first.
No surveillance vendor will volunteer this in a pitch deck: their model is only as honest as the governments reporting into it, and an outbreak concealed for trade or political reasons will defeat any algorithm trained on official data. Buyers should ask every vendor one question before signing: show me a case where your system caught something a government did not want reported. The answer, or the silence, tells you what you are buying. The broader skepticism in the AI ROI crisis analysis applies here with full force, because spending on capability without spending on the conditions for impact is how technology budgets turn into monuments.
Frequently asked questions
Can AI predict the next pandemic?
AI can identify high-risk viruses, detect outbreak signals earlier than manual surveillance, and forecast where disease risk will grow, but it cannot guarantee prediction of a specific pandemic. Current systems discovered more than 70,000 previously unknown RNA virus species and flagged COVID-19 before official announcements, yet scientists caution that fundamental uncertainties in pathogen emergence remain beyond any model.
What is the biggest weakness of AI disease surveillance?
The biggest weakness of AI disease surveillance is the data pipeline, because models can only process what humans collect, report, and share. Underfunded field sampling, political pressure to conceal outbreaks, fragmented agency data, and weak community trust all degrade predictions before the model sees a single record.
How much would pandemic prevention cost compared to response?
A 2022 World Bank estimate reported by Nature values prevention guided by a One Health approach at up to $11.5 billion per year, roughly one-third the cost of managing pandemics after they begin. The economics favor prevention by a wide margin, but political budgets still favor emergency response.
Final view
AI will help hunt the next pandemic, and the scientists building these tools deserve more funding, not less. The argument here concerns order of operations. Leaders who buy the model first will own an elegant forecast of a crisis they failed to prevent, while leaders who fund sampling, trust, data plumbing, and decision rights first will give the model something worth predicting.
The choice lands this budget cycle, in ministries, foundations, and health systems planning next year's technology spend. If your organization needs an independent view on where AI investment produces operational results rather than demonstrations, MD-Konsult consulting for AI strategy and technology decisions provides that work.
For a deeper treatment of AI strategy, governance, and operating models, read the AI Strategy Book.
0 Comments